GSK Divests Anesthetic Drugs to Aspen

15.09.2016 - Subject to the usual antitrust and regulatory approvals, UK drugmaker Glaxo SmithKline (GSK) has agreed to sell its portfolio of anesthetic drugs to South Africa’s Aspen Pharmacare...